The purchase of quality medicines and medical equipment remains a major problem in many rural areas of Africa, undermining the promise of universal access to care. Hspitals and health centers are not always able to obtain regular supplies from regional or national public procurement centers. Management of pharmacies is not always optimal resulting in stockouts and expiry date overruns. Private pharmacies are few in rural areas.
Their poor controlled supply circuits favor the presence of fake drugs that has become a real public health problem. The lack of pharmaceutical distribution relays prevents the creation of a drug market outside capital cities. This situation does not encourage the commitment of international companies.
The creation of reliable distribution networks in Africa is therefore an important issue. In some countries, the supply of pharmacies is provided by a buying cooperative (a wholesaler owned by the participating pharmacies).
We would like to explore
- how to develop pharmaceutical distribution networks in African countries
- Whether distribution cooperatives are a suitable model for Africa
In order to improve the quality of care and optimize medical prescriptions to treat children’s acute illnesses in LMICs, several humanitarian and development organisations together with scientific institutions have developed electronic versions of the clinical pathway recommended by the World Health Organisation (WHO)’s Integrated Management of Childhood Illness (IMCI).
The creation of these Clinical Decision Support Systems (CDSS) - taking into account contextualised users’ experience - led to different interpretations/modifications of the clinical pathway content and generated critical learning for further efforts to promote and harmonise the digitisation of clinical guidelines.
A thorough review of these innovative digitisation processes is timely in the context of global efforts to improve the harmonisation of e-health innovations and the coordination of global health actors in this area, as advocated in the WHO resolution on digital health and the introduction of the Principles of Donor Alignment for Digital Health.
To be effective, public health actions can no longer be carried out in isolation. There is a growing need to create synergies between actors, to share information, health data and research results.
The Geneva Health Forum, like other platforms, aims to bring together the various actors working in global health and wish to facilitate initiatives. However, it is sometimes difficult to find one's way through the ever-growing number of information and stakeholder networks. The development of artificial intelligence algorithms makes it possible to create increasingly important systems for recommending information or people.
The goal of a recommender system is to generate meaningful recommendations to a collection of users for items, products or persons that might interest them. Here, we aim to design and develop recommender systems adapted to the needs and the requirements of public health actors to facilitate collaboration and knowledge exchange around public health thematic.
Switzerland holds a unique position of being home to numerous public and private sector healthcare organizations, academic institutions conducting critical research as well as commercial healthcare and biotech entities which are active in the women’s health space. Taken together, these organizations are engaged in a range of activities related to women’s health needs and advocating for addressing gender biases and inequalities in health, supporting access to SRH services/commodities, defending SRH and rights of individuals, and are active in a broad range of issues relevant to women’s health within the broader global health context. Despite these common interests, many of these actors do not always engage with one another outside of their immediate networks or beyond specific/direct organization to organization partnerships and lack a common platform to come together to exchange and collaborate on shared issues and actions.
The objective of the Swiss Women’s Health Alliance is to offer regular opportunities and a forum for exchange for Swiss organizations, companies and individuals working in women’s health to come together and facilitate collaboration and joint activities. We aim to establish a community committed to addressing key and emerging global health concerns and other gender-related challenges that impact women’s overall health and well-being, with an initial priority on SRH issues and other issues that are directly or indirectly impacted by a lack of universal access to SRH commodities, services, and rights.
Cervical cancer is a leading cause of death for women in resource-poor countries. To reduce mortality, it is essential to set up a screening of patients to diagnose lesions as early as possible. WHO has published recommendations on screening for HPV infections and on VIA / VILI.
Many pilot projects have been developed in recent years using different approaches. New tools allow us to envisage new approaches.
Since the WHO declaration defining cervical cancer as a public health priority, many organizations have taken action. We must go beyond the pilot project stage to integrate the fight against cervical cancer into the healthcare system.
Our workshop aims to identify key lessons learned from the field actions for the screening and diagnosis of cervical cancer in LMICs.
Noma (cancrum oris) is a gangrenous disease which predominantly affects children aged 2-6 years living in extreme poverty. With a high mortality rate, noma leaves survivors with significant aesthetic and functional sequelae, suffering social isolation, stigmatisation and discrimination. If diagnosed early, noma’s full onset is preventable and treatable with inexpensive intervention (rehydration, antibiotics, mouth rinses and nutritional support).
Yet, the majority of children likely do not receive medical attention, or receive it too late to save their faces and often their lives. Surgical rehabilitation is expensive and often not feasible in the countries where the patients live. Institutionally, noma largely remains trapped in a ‘vicious circle’ of neglect perpetuated by a lack of accurate empirical data, a feeble advocacy focus, and governmental and intergovernmental inaction.
Whilst some progress has been made by experts in the field and non-governmental organizations, research mainly consists of descriptive clinical case studies.
To address the empirical and theoretical gaps in the current understanding of noma, would allow for targeted inter- and governmental policy interventions aimed at the prevention and treatment of noma and the redress of human rights violations suffered by those at risk of noma and survivors.
L’information et la communication deviennent essentiels dans de nombreux secteurs de la société. La santé n’échange pas à ce constat. Le besoin de dialoguer avec les communautés lors de crises sanitaires, l’implication actives des patients et de leur famille dans la prise en charge des maladies chroniques, l’amélioration des conditions de vie sont autant d’exemples qui montre la nécessité d’une bonne information et d’un dialogue public sur les questions de santé.
Les médias ont un rôle fondamental à jouer. Cela concerne aussi bien les journaux papier, que les radios locales ou nationales, les outils électronique (site, réseaux sociaux, téléphone mobile…).
Il est alors nécessaire d’avoir des journalistes maitrisant les concepts de santé publiques et comprenant les enjeux environnementaux. Le développement de formations pour renforcer la capacité des journalistes à aborder les questions de santé et d’environnement en Afrique francophone est alors un enjeu important.
Notre réflexion lors de ce workshop souhaite se concentrer sur l’Afrique francophone.